Catalent Cell & Gene Therapy

Silver Sponsor


Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. Catalent recently acquired MaSTherCell, adding expertise in autologous and allogeneic cell therapy development and manufacturing to position Catalent as a premier technology, development, and manufacturing partner for innovators across the entire field of advanced biotherapeutics.
Contract Manufacturing

Social media

Contact details

Products & Services


Documents & Links